X
AZ forges surprise R&D deal with virus gene therapy biotech
https://pharmaphorum.com/top-pharmaceutical-companies/astrazeneca/az-steps-avv-field-medimmune-4dmt/
MedImmune
AstraZeneca’s respiratory biologic fails again in COPD
AstraZeneca (AZ) and MedImmune, have announced that the latest trial of Fasenra (benralizumab) in patients with moderate-to-very-severe chronic obstructive pulmonary disease (COPD) did not provide a statistically-significant reduction in exacerbations.
Bahija Jallal: pharma’s Woman of the Year in a landmark 12 months
AstraZeneca’s Bahija Jallal was named the Healthcare Businesswomen’s Association (HBA) Women of the Year for 2017 – in what turned out to a watershed year for women’s rights.
MedImmune launches Digital Health Challenge in the UK
Start ups and entrepreneurs in the UK who have developed or are looking to create a digital healthcare solution are being invited to submit entries to a new prize fund organised by Medimmune.
Hear from MedImmune and Ipsen at SMi’s Injectable Drug Delivery 2018
Launch of Injectable Drug Delivery
US authorities refuse to use AZ’s nasal flu vaccine
Company takes $80m hit.
